SYLVARIS

Serial Number 75319296
614

Registration Progress

Application Filed
Jul 3, 1997
Under Examination
Jul 7, 1998
Approved for Publication
Mar 13, 1998
Published for Opposition
Apr 14, 1998
Registered

Re-Apply for This Trademark

This trademark is no longer active. You may be able to file a new application for the same or similar mark.
Mark: SYLVARIS
Previous Owner: Amgen Inc.
Classes: 005

Trademark Image

SYLVARIS

Basic Information

Serial Number
75319296
Filing Date
July 3, 1997
Published for Opposition
April 14, 1998
Drawing Code
1000

Status Summary

Current Status
Inactive
Status Code
614
Status Date
Oct 18, 2001
Classes
005

Rights Holder

Amgen Inc.

03
Address
1840 DeHavilland Drive
Thousand Oaks, CA 913201789

Ownership History

Amgen Inc.

Original Applicant
03
Thousand Oaks, CA

Amgen Inc.

Owner at Publication
03
Thousand Oaks, CA

Legal Representation

Attorney
MARK I FELDMAN

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

15 events
Date Code Type Description Documents
Jan 26, 2001 PETR I PETITION TO REVIVE-RECEIVED Loading...
May 19, 2001 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Aug 25, 2000 EX4G S SOU EXTENSION 4 GRANTED Loading...
Jul 6, 2000 EXT4 S SOU EXTENSION 4 FILED Loading...
Jan 3, 2000 EX3G S SOU EXTENSION 3 GRANTED Loading...
Nov 18, 1999 EXT3 S SOU EXTENSION 3 FILED Loading...
Jul 13, 1999 EX2G S SOU EXTENSION 2 GRANTED Loading...
Jun 14, 1999 EXT2 S SOU EXTENSION 2 FILED Loading...
Dec 28, 1998 EX1G S SOU EXTENSION 1 GRANTED Loading...
Dec 3, 1998 EXT1 S SOU EXTENSION 1 FILED Loading...
Jul 7, 1998 NOAM O NOA MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 14, 1998 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 13, 1998 NPUB O NOTICE OF PUBLICATION Loading...
Feb 10, 1998 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 3, 1998 DOCK D ASSIGNED TO EXAMINER Loading...

Detailed Classifications

Class 005
prescription pharmaceuticals for treatment of neurological disorders, for promoting growth and differentiation of neurons and for preventing neuronal death
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005